Macular microvascular and structural changes on optical coherence tomography angiography in atypical optic neuritis

Figure 1 Schematic representation of the methodology for the study. NMOSD: Neuromyelitis optica spectrum disorders; MOGAD: Myelin oligodendrocyte glycoprotein antibody disorder; MVD: Macular vascular density; AQP 4: Aquaporin-4; OCTA: Optical coherence tomography angiography; GCIPL: Ganglion cell + inner plexiform layer.

Figure 2 Reduction in macular vascular density in neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disorder affected as well as unaffected eyes compared to controls. NMOSD: Neuromyelitis optica spectrum disorders; MOGAD: Myelin oligodendrocyte glycoprotein antibody disorder; MVD: Macular vascular density.

Figure 3 Ganglion cell + inner plexiform layer thickness in neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disorder eyes compared with controls. NMOSD: Neuromyelitis optica spectrum disorders; MOGAD: Myelin oligodendrocyte glycoprotein antibody disorder; GCIPL: Ganglion cell + inner plexiform layer.